Knowledge and awareness of the general population and healthcare providers about retinoblastoma: It is time to know the glow

Author:

Naser Abdallah Y.1ORCID,Alrawashdeh Hamzeh Mohammad2,Alwafi Hassan3ORCID,Alyami Hamad S.4ORCID,Dahmash Eman Z.1ORCID,Ghoul Imene5,Shishtawi Anas Amin6,Abdelwahab Ghada Mohammad1,Qadus Sami1,Taybeh Esra’1,Abuthawabeh Rasha1,Hassanin Fadi7,Alhartani Yosra J.1,Alyami Mohammad H.4,Salawati Emad M.8,Alwan Salwan Salah1

Affiliation:

1. Department of Applied Pharmaceutical Sciences and Clinical Pharmacy Faculty of Pharmacy Isra University Amman Jordan

2. Sharif Eye Centers Irbid Jordan

3. Faculty of Medicine Umm Alqura University Mecca Saudi Arabia

4. Department of Pharmaceutics College of Pharmacy Najran University Najran Saudi Arabia

5. Paediatric Department Ibn AL Haytham Hospital Amman Jordan

6. Faculty of Medicine University of Science and Technology Sanaa Yemen

7. Ophthalmology Department college of medicine Jeddah University Jeddah Saudi Arabia

8. Family medicine Department Faculty of medicine King Abdulaziz University Jeddah Saudi Arabia

Publisher

Hindawi Limited

Subject

General Medicine

Reference35 articles.

1. World Health Organization.RETINOBLASTOMA: Union for International Cancer Control 2014 Review of Cancer Medicines on the WHO List of Essential Medicines.2014.

2. Retinoblastoma

3. Outcome of retinoblastoma in east Africa

4. Diagnosis and current management of retinoblastoma

5. Neonatal retinoblastoma

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3